Sulfasalazine Tablets/Capsule Suppliers & Bulk Manufacturers
Available Forms: Tablet/Capsules
Available Strengths: 500 mg, 1000 mg
Reference Brands: Azulfidine(US); Salazopyrin(EU)
Category:
Antibiotics
Sulfasalazine inhibits bacterial enzymes, reducing inflammatory responses and joint damage in rheumatoid arthritis. It also suppresses immune activity, decreasing cytokine production. Benefits include slowing disease progression, reducing joint pain and swelling, and improving function. It’s effective in managing RA and inflammatory bowel disease with a good safety profile when monitored properly.
Sulfasalazine Tablets/Capsule is available in Tablet/Capsules
and strengths such as 500 mg, 1000 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sulfasalazine Tablets/Capsule is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sulfasalazine Tablets/Capsule can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sulfasalazine tablets are approved in both the EU and US for treating rheumatoid arthritis and inflammatory bowel disease. In the EU, brands like Salazopyrin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans, for approval and ongoing safety monitoring. For expert regulatory support, dossier management, and registration services, visit PharmaTradz. We ensure seamless market access for sulfasalazine tablets, adhering to European and US standards for safe, effective disease management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing